Form D · Biotechnology
RHEONIX INC
Ithaca, NY · CIK 0001454559
Offering snapshot reported Jun 18, 2020 · SEC filing
- Reported sold
- Yet to sell Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 18, 2020 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Oct 9, 2015 | Initial | $21,862,496 | No comparison | 24 | SEC filing |
| Dec 19, 2013 | Amendment | $12,000,000 | $6,000,000vs Dec 2, 2013 | 51 | SEC filing |
| Dec 2, 2013 | Initial | $6,000,000 | No comparison | 51 | SEC filing |
| Feb 14, 2012 | Initial | $6,000,000 | No comparison | 54 | SEC filing |
| Jan 14, 2010 | Initial | $11,524,758 | No comparison | 54 | SEC filing |
| Jan 15, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-369240
Source: Form D, filed Jun 18, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| John Albert Brenner | Executive |
| Anthony Eisenhut | Executive |
| Gregory Galvin | Executive |
| Christopher Smith | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10 Brown Road Suite 103
Ithaca, NY, 14850
Ithaca, NY, 14850